This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...

Health care executives continue to reimagine and reshape their organizations. Their ideas were developing in real time during ...

Koreas biotech firms strive for growth amid investment challenges at JP Morgan event K-Bio executives highlight new strategies to adapt in a challenging investment landscape at a major healthcare gath ...

Another year at the J.P. Morgan Healthcare Conference is in the books. | While major payers skipped out on this year’s event, ...

Biogen’s effort to buy Sage against the board’s wishes and a long-time effort by investor Alcorn to scuttle Aurion’s IPO ...

I just wrapped up a productive week at the 2025 JP Morgan Healthcare Conference, where the world’s biopharma industry converges in San Francisco to find opportunities for dealmaking, advance ...

A major conference that took place earlier this month is set to return to San Francisco next year, according to SF Mayor Daniel Lurie’s office. The J.P. Morgan ...

Erin Whaley, Tammy Ward Woffenden and Paul M. Mahoney Jr. of Troutman Pepper Locke LLP discuss key market and legal developments impacting health care delivery that will be top of mind for investors ...

This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties following the fatal shooting of UnitedHealthcare’s CEO in December.

The Westin St. Francis Hotel in Union Square will once again be host for one of the biggest conventions in the city--the J.P. Morgan Healthcare Conference. The conference includes global industry ...